Algert Global LLC Grows Position in Chemed Co. (NYSE:CHE)

Algert Global LLC raised its position in Chemed Co. (NYSE:CHE) by 10.8% during the second quarter, HoldingsChannel.com reports. The firm owned 11,540 shares of the company’s stock after purchasing an additional 1,129 shares during the period. Algert Global LLC’s holdings in Chemed were worth $6,261,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Chemed in the first quarter worth approximately $1,064,000. ProShare Advisors LLC lifted its position in shares of Chemed by 6,288.9% during the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after purchasing an additional 49,808 shares during the last quarter. Cim LLC bought a new stake in shares of Chemed during the fourth quarter worth $1,328,000. Sei Investments Co. boosted its stake in shares of Chemed by 4.5% during the first quarter. Sei Investments Co. now owns 41,336 shares of the company’s stock valued at $26,535,000 after purchasing an additional 1,780 shares during the period. Finally, American National Bank & Trust Co. VA bought a new position in shares of Chemed in the first quarter worth about $3,122,000. Institutional investors own 95.85% of the company’s stock.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the completion of the sale, the executive vice president now directly owns 6,109 shares of the company’s stock, valued at approximately $3,478,159.15. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,144 shares of company stock valued at $5,264,839. 3.32% of the stock is currently owned by corporate insiders.

Chemed Price Performance

CHE stock opened at $599.04 on Monday. Chemed Co. has a 12 month low of $497.36 and a 12 month high of $654.62. The firm’s 50-day moving average is $574.54 and its 200 day moving average is $575.46. The company has a market capitalization of $9.07 billion, a PE ratio of 32.24, a P/E/G ratio of 2.40 and a beta of 0.44.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The company had revenue of $595.88 million for the quarter, compared to analysts’ expectations of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business’s revenue was up 7.6% compared to the same quarter last year. During the same period last year, the business posted $4.71 earnings per share. Sell-side analysts forecast that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. This is a boost from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. Chemed’s dividend payout ratio is currently 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.